Order Article Reprints

Criscuolo E, De Sciscio ML, De Cristofaro A, Nicoara C, Maccarrone M, Fezza F. Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1. Pharmaceuticals. 2023; 16(12):1678. https://doi.org/10.3390/ph16121678

Criscuolo, Emanuele, Maria Laura De Sciscio, Angela De Cristofaro, Catalin Nicoara, Mauro Maccarrone, and Filomena Fezza. 2023. "Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1" Pharmaceuticals 16, no. 12: 1678. https://doi.org/10.3390/ph16121678

Criscuolo, E., De Sciscio, M. L., De Cristofaro, A., Nicoara, C., Maccarrone, M., & Fezza, F. (2023). Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1. Pharmaceuticals, 16(12), 1678. https://doi.org/10.3390/ph16121678